Furthermore, the knockdown of NEAT1 could reverse the paclitaxel resistance in non-small cell lung cancer (NSCLC) by inducing apoptosis by increasing cleaved PARP and cleaved caspase-3 expression 31. Here, PARP1 is linked to non-small cell lung carcinoma.